DPP-4 Inhibition, Incretins and Islet Function

NCT02089438 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Type 2 Diabetes

Interventions

DRUG: Saxagliptin
DRUG: Vildagliptin
DRUG: Sitagliptin

Sponsor

Lund University